Multiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicity
Genome editing technologies enable the rapid interrogation of genetic alterations. Here, the authors present a CRISPR/Cas9-based platform to simultaneously investigate multiple activating point mutations in de novo cancers in mice; and generate panels of Kras-variants in different tissues to induce...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ec34a2e663bb4e9aa7d634750cb16aee |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ec34a2e663bb4e9aa7d634750cb16aee |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ec34a2e663bb4e9aa7d634750cb16aee2021-12-02T14:40:34ZMultiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicity10.1038/s41467-017-01519-y2041-1723https://doaj.org/article/ec34a2e663bb4e9aa7d634750cb16aee2017-12-01T00:00:00Zhttps://doi.org/10.1038/s41467-017-01519-yhttps://doaj.org/toc/2041-1723Genome editing technologies enable the rapid interrogation of genetic alterations. Here, the authors present a CRISPR/Cas9-based platform to simultaneously investigate multiple activating point mutations in de novo cancers in mice; and generate panels of Kras-variants in different tissues to induce cancer.Ian P. WintersShin-Heng ChiouNicole K. PaulkChristopher D. McFarlandPranav V. LalgudiRosanna K. MaLeszek LisowskiAndrew J. ConnollyDmitri A. PetrovMark A. KayMonte M. WinslowNature PortfolioarticleScienceQENNature Communications, Vol 8, Iss 1, Pp 1-16 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Ian P. Winters Shin-Heng Chiou Nicole K. Paulk Christopher D. McFarland Pranav V. Lalgudi Rosanna K. Ma Leszek Lisowski Andrew J. Connolly Dmitri A. Petrov Mark A. Kay Monte M. Winslow Multiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicity |
description |
Genome editing technologies enable the rapid interrogation of genetic alterations. Here, the authors present a CRISPR/Cas9-based platform to simultaneously investigate multiple activating point mutations in de novo cancers in mice; and generate panels of Kras-variants in different tissues to induce cancer. |
format |
article |
author |
Ian P. Winters Shin-Heng Chiou Nicole K. Paulk Christopher D. McFarland Pranav V. Lalgudi Rosanna K. Ma Leszek Lisowski Andrew J. Connolly Dmitri A. Petrov Mark A. Kay Monte M. Winslow |
author_facet |
Ian P. Winters Shin-Heng Chiou Nicole K. Paulk Christopher D. McFarland Pranav V. Lalgudi Rosanna K. Ma Leszek Lisowski Andrew J. Connolly Dmitri A. Petrov Mark A. Kay Monte M. Winslow |
author_sort |
Ian P. Winters |
title |
Multiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicity |
title_short |
Multiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicity |
title_full |
Multiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicity |
title_fullStr |
Multiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicity |
title_full_unstemmed |
Multiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicity |
title_sort |
multiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of kras variant oncogenicity |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/ec34a2e663bb4e9aa7d634750cb16aee |
work_keys_str_mv |
AT ianpwinters multiplexedinvivohomologydirectedrepairandtumorbarcodingenablesparallelquantificationofkrasvariantoncogenicity AT shinhengchiou multiplexedinvivohomologydirectedrepairandtumorbarcodingenablesparallelquantificationofkrasvariantoncogenicity AT nicolekpaulk multiplexedinvivohomologydirectedrepairandtumorbarcodingenablesparallelquantificationofkrasvariantoncogenicity AT christopherdmcfarland multiplexedinvivohomologydirectedrepairandtumorbarcodingenablesparallelquantificationofkrasvariantoncogenicity AT pranavvlalgudi multiplexedinvivohomologydirectedrepairandtumorbarcodingenablesparallelquantificationofkrasvariantoncogenicity AT rosannakma multiplexedinvivohomologydirectedrepairandtumorbarcodingenablesparallelquantificationofkrasvariantoncogenicity AT leszeklisowski multiplexedinvivohomologydirectedrepairandtumorbarcodingenablesparallelquantificationofkrasvariantoncogenicity AT andrewjconnolly multiplexedinvivohomologydirectedrepairandtumorbarcodingenablesparallelquantificationofkrasvariantoncogenicity AT dmitriapetrov multiplexedinvivohomologydirectedrepairandtumorbarcodingenablesparallelquantificationofkrasvariantoncogenicity AT markakay multiplexedinvivohomologydirectedrepairandtumorbarcodingenablesparallelquantificationofkrasvariantoncogenicity AT montemwinslow multiplexedinvivohomologydirectedrepairandtumorbarcodingenablesparallelquantificationofkrasvariantoncogenicity |
_version_ |
1718390270492409856 |